Giuseppina De Feudis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giuseppina De Feudis has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Anouk Savir Kadmon
Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
13 shared publications - Carmela Rubolino
Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia, Milan, Italy
13 shared publications - Eldad David Shulman
Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
13 shared publications - Eli Reuveni
Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
13 shared publications - Emma M. Campagnolo
National Cancer Institute 1 Cancer Data Science Laboratory, Center for Cancer Research National Institutes of Health, Bethesda, Maryland
13 shared publications - Eytan Ruppin
Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
13 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Gene set enrichment analysis of differential protein expression between the highly-aneuploid clones (SS51, SS111) and pseudo-diploid clones (SS48, SS31)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Gene set enrichment analysis of differential protein expression between the highly-aneuploid clones (SS51, SS111) and pseudo-diploid clones (SS48, SS31)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between the highly-aneuploid clones (SS51, SS111) and the pseudo-diploid clone (SS48).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between the highly-aneuploid clones (SS51, SS111) and the pseudo-diploid clone (SS48).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
PRISM screen results of human cancer cell lines treated with bortezomib, in the absence or presence of reversine
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
PRISM screen results of human cancer cell lines treated with bortezomib, in the absence or presence of reversine
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Details of cell lines, reagents and oligonucleotides used in the study
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Details of cell lines, reagents and oligonucleotides used in the study
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figures 1-8 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Supplementary Figure 1: Dosage compensation in trisomic cells occurs at both mRNA and protein levels (related to Fig. 1). Supplementary Figure 2: RNA degradation does not confound the results of the differential gene expression analyses (related to Fig. 2). Supplementary Figure 3: Aneuploid clones activate the nonsense-mediated decay (NMD) pathway, and depend on it for downregulating their gene expression (related to Fig. 3). Supplementary Figure 4: Increased dependency on the nonsense-mediated decay pathway is a general feature of aneuploid cells (related to Fig. 3). Supplementary Figure 5: Trisomic clones activate the miRNA-mediated RNA degradation pathway, and depend on it for downregulating their gene expression (related to Fig. 4). Supplementary Figure 6: Aneuploid cells depend on miRNA machinery cofactors PRKRA and TARBP2 (related to Fig. 4). Supplementary Figure 7: Multiple models of aneuploid cells experience proteotoxic stress and attenuate protein translation (related to Fig. 5). Supplementary Figure 8: Multiple models of aneuploid cells activate the proteasome, and depend on its activity for downregulating their protein expression (related to Fig. 6).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures 1-8 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Supplementary Figure 1: Dosage compensation in trisomic cells occurs at both mRNA and protein levels (related to Fig. 1). Supplementary Figure 2: RNA degradation does not confound the results of the differential gene expression analyses (related to Fig. 2). Supplementary Figure 3: Aneuploid clones activate the nonsense-mediated decay (NMD) pathway, and depend on it for downregulating their gene expression (related to Fig. 3). Supplementary Figure 4: Increased dependency on the nonsense-mediated decay pathway is a general feature of aneuploid cells (related to Fig. 3). Supplementary Figure 5: Trisomic clones activate the miRNA-mediated RNA degradation pathway, and depend on it for downregulating their gene expression (related to Fig. 4). Supplementary Figure 6: Aneuploid cells depend on miRNA machinery cofactors PRKRA and TARBP2 (related to Fig. 4). Supplementary Figure 7: Multiple models of aneuploid cells experience proteotoxic stress and attenuate protein translation (related to Fig. 5). Supplementary Figure 8: Multiple models of aneuploid cells activate the proteasome, and depend on its activity for downregulating their protein expression (related to Fig. 6).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between all aneuploid clones (SS6, SS119, SS51, SS111) and the pseudo-diploid clone (SS48)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between all aneuploid clones (SS6, SS119, SS51, SS111) and the pseudo-diploid clone (SS48)
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between all aneuploid clones (SS6, SS119, SS51, SS111) and the pseudo-diploid clone (SS48)
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between all aneuploid clones (SS6, SS119, SS51, SS111) and the pseudo-diploid clone (SS48)
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Gene set enrichment analysis of differential protein expression between the highly-aneuploid clones (SS51, SS111) and pseudo-diploid clones (SS48, SS31)
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Gene set enrichment analysis of differential protein expression between the highly-aneuploid clones (SS51, SS111) and pseudo-diploid clones (SS48, SS31)
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
PRISM screen results of human cancer cell lines treated with bortezomib, in the absence or presence of reversine
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
PRISM screen results of human cancer cell lines treated with bortezomib, in the absence or presence of reversine
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figures 1-8 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Supplementary Figure 1: Dosage compensation in trisomic cells occurs at both mRNA and protein levels (related to Fig. 1). Supplementary Figure 2: RNA degradation does not confound the results of the differential gene expression analyses (related to Fig. 2). Supplementary Figure 3: Aneuploid clones activate the nonsense-mediated decay (NMD) pathway, and depend on it for downregulating their gene expression (related to Fig. 3). Supplementary Figure 4: Increased dependency on the nonsense-mediated decay pathway is a general feature of aneuploid cells (related to Fig. 3). Supplementary Figure 5: Trisomic clones activate the miRNA-mediated RNA degradation pathway, and depend on it for downregulating their gene expression (related to Fig. 4). Supplementary Figure 6: Aneuploid cells depend on miRNA machinery cofactors PRKRA and TARBP2 (related to Fig. 4). Supplementary Figure 7: Multiple models of aneuploid cells experience proteotoxic stress and attenuate protein translation (related to Fig. 5). Supplementary Figure 8: Multiple models of aneuploid cells activate the proteasome, and depend on its activity for downregulating their protein expression (related to Fig. 6).
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures 1-8 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Supplementary Figure 1: Dosage compensation in trisomic cells occurs at both mRNA and protein levels (related to Fig. 1). Supplementary Figure 2: RNA degradation does not confound the results of the differential gene expression analyses (related to Fig. 2). Supplementary Figure 3: Aneuploid clones activate the nonsense-mediated decay (NMD) pathway, and depend on it for downregulating their gene expression (related to Fig. 3). Supplementary Figure 4: Increased dependency on the nonsense-mediated decay pathway is a general feature of aneuploid cells (related to Fig. 3). Supplementary Figure 5: Trisomic clones activate the miRNA-mediated RNA degradation pathway, and depend on it for downregulating their gene expression (related to Fig. 4). Supplementary Figure 6: Aneuploid cells depend on miRNA machinery cofactors PRKRA and TARBP2 (related to Fig. 4). Supplementary Figure 7: Multiple models of aneuploid cells experience proteotoxic stress and attenuate protein translation (related to Fig. 5). Supplementary Figure 8: Multiple models of aneuploid cells activate the proteasome, and depend on its activity for downregulating their protein expression (related to Fig. 6).